APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drugs and Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Contraceptive Drugs and Devices Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchContraceptive Drugs and Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drugs and Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Contraceptive Drugs and Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drugs and Devices Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drugs and Devices Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Drugs and Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Contraceptive Drugs and Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Contraceptive Drugs and Devices market include Teva Pharmaceutical Industries, Merck, Pfizer, Bayer Healthcare, Warmer Chilcott, Pantarhei Bioscience, Mayer Laboratories, Church & Dwight and BioSante Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Drugs and Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Drugs and Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Drugs and Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Drugs and Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Drugs and Devices Segment by Company

Teva Pharmaceutical Industries

Merck

Pfizer

Bayer Healthcare

Warmer Chilcott

Pantarhei Bioscience

Mayer Laboratories

Church & Dwight

BioSante Pharmaceuticals

Agile Therapeutics

Contraceptive Drugs and Devices Segment by Type

Injectable Contraceptive Drugs

Vaginal

Male/Female Contraceptive Devices

Oral

Contraceptive Drugs and Devices Segment by Application

Hospitals

Pharmacies

Others

Contraceptive Drugs and Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contraceptive Drugs and Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contraceptive Drugs and Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contraceptive Drugs and Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Contraceptive Drugs and Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drugs and Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drugs and Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drugs and Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Drugs and Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contraceptive Drugs and Devices industry.

Chapter 3: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contraceptive Drugs and Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contraceptive Drugs and Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Drugs and Devices Industry Trends Table 2. Contraceptive Drugs and Devices Industry Drivers Table 3. Contraceptive Drugs and Devices Industry Opportunities and Challenges Table 4. Contraceptive Drugs and Devices Industry Restraints Table 5. Global Contraceptive Drugs and Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contraceptive Drugs and Devices Revenue Share by Company (2021-2026) Table 7. Global Contraceptive Drugs and Devices Sales Volume by Company (k units) & (2021-2026) Table 8. Global Contraceptive Drugs and Devices Sales Volume Share by Company (2021-2026) Table 9. Global Contraceptive Drugs and Devices Average Price (US$/unit) of Company (2021-2026) Table 10. Global Contraceptive Drugs and Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contraceptive Drugs and Devices Key Company Manufacturing Base & Headquarters Table 12. Global Contraceptive Drugs and Devices Company, Product Type & Application Table 13. Global Contraceptive Drugs and Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injectable Contraceptive Drugs Table 18. Significant Companies of Vaginal Table 19. Significant Companies of Male/Female Contraceptive Devices Table 20. Significant Companies of Oral Table 21. Global Contraceptive Drugs and Devices Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Contraceptive Drugs and Devices Sales Volume by Type (2021-2026) & (k units) Table 23. Global Contraceptive Drugs and Devices Sales Volume by Type (2027-2032) & (k units) Table 24. Global Contraceptive Drugs and Devices Sales Volume Share by Type (2021-2026) Table 25. Global Contraceptive Drugs and Devices Sales Volume Share by Type (2027-2032) Table 26. Global Contraceptive Drugs and Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Contraceptive Drugs and Devices Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Contraceptive Drugs and Devices Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Contraceptive Drugs and Devices Sales Value Share by Type (2021-2026) Table 30. Global Contraceptive Drugs and Devices Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Pharmacies Table 33. Significant Companies of Others Table 34. Global Contraceptive Drugs and Devices Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Contraceptive Drugs and Devices Sales Volume by Application (2021-2026) & (k units) Table 36. Global Contraceptive Drugs and Devices Sales Volume by Application (2027-2032) & (k units) Table 37. Global Contraceptive Drugs and Devices Sales Volume Share by Application (2021-2026) Table 38. Global Contraceptive Drugs and Devices Sales Volume Share by Application (2027-2032) Table 39. Global Contraceptive Drugs and Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Contraceptive Drugs and Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Contraceptive Drugs and Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Contraceptive Drugs and Devices Sales Value Share by Application (2021-2026) Table 43. Global Contraceptive Drugs and Devices Sales Value Share by Application (2027-2032) Table 44. Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Contraceptive Drugs and Devices Sales by Region (2021-2026) & (k units) Table 46. Global Contraceptive Drugs and Devices Sales Market Share by Region (2021-2026) Table 47. Global Contraceptive Drugs and Devices Sales by Region (2027-2032) & (k units) Table 48. Global Contraceptive Drugs and Devices Sales Market Share by Region (2027-2032) Table 49. Global Contraceptive Drugs and Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Contraceptive Drugs and Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Contraceptive Drugs and Devices Sales Value Share by Region (2021-2026) Table 52. Global Contraceptive Drugs and Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Contraceptive Drugs and Devices Sales Value Share by Region (2027-2032) Table 54. Global Contraceptive Drugs and Devices Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Contraceptive Drugs and Devices Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Contraceptive Drugs and Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 59. Global Contraceptive Drugs and Devices Sales Market Share by Country (2021-2026) Table 60. Global Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 61. Global Contraceptive Drugs and Devices Sales Market Share by Country (2027-2032) Table 62. Global Contraceptive Drugs and Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Contraceptive Drugs and Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Contraceptive Drugs and Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Contraceptive Drugs and Devices Sales Value Market Share by Country (2027-2032) Table 66. Teva Pharmaceutical Industries Company Information Table 67. Teva Pharmaceutical Industries Business Overview Table 68. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio Table 70. Teva Pharmaceutical Industries Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Merck Contraceptive Drugs and Devices Product Portfolio Table 75. Merck Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Contraceptive Drugs and Devices Product Portfolio Table 80. Pfizer Recent Development Table 81. Bayer Healthcare Company Information Table 82. Bayer Healthcare Business Overview Table 83. Bayer Healthcare Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio Table 85. Bayer Healthcare Recent Development Table 86. Warmer Chilcott Company Information Table 87. Warmer Chilcott Business Overview Table 88. Warmer Chilcott Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio Table 90. Warmer Chilcott Recent Development Table 91. Pantarhei Bioscience Company Information Table 92. Pantarhei Bioscience Business Overview Table 93. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio Table 95. Pantarhei Bioscience Recent Development Table 96. Mayer Laboratories Company Information Table 97. Mayer Laboratories Business Overview Table 98. Mayer Laboratories Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio Table 100. Mayer Laboratories Recent Development Table 101. Church & Dwight Company Information Table 102. Church & Dwight Business Overview Table 103. Church & Dwight Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Church & Dwight Contraceptive Drugs and Devices Product Portfolio Table 105. Church & Dwight Recent Development Table 106. BioSante Pharmaceuticals Company Information Table 107. BioSante Pharmaceuticals Business Overview Table 108. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio Table 110. BioSante Pharmaceuticals Recent Development Table 111. Agile Therapeutics Company Information Table 112. Agile Therapeutics Business Overview Table 113. Agile Therapeutics Contraceptive Drugs and Devices Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio Table 115. Agile Therapeutics Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Contraceptive Drugs and Devices Distributors List Table 119. Contraceptive Drugs and Devices Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Contraceptive Drugs and Devices Product Image Figure 2. Global Contraceptive Drugs and Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Drugs and Devices Sales (2021-2032) & (k units) Figure 5. Global Contraceptive Drugs and Devices Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Contraceptive Drugs and Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injectable Contraceptive Drugs Image Figure 10. Vaginal Image Figure 11. Male/Female Contraceptive Devices Image Figure 12. Oral Image Figure 13. Global Contraceptive Drugs and Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Contraceptive Drugs and Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Contraceptive Drugs and Devices Sales Volume Share by Type (2021-2032) Figure 16. Global Contraceptive Drugs and Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Contraceptive Drugs and Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Contraceptive Drugs and Devices Sales Value Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Pharmacies Image Figure 21. Others Image Figure 22. Global Contraceptive Drugs and Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Contraceptive Drugs and Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Contraceptive Drugs and Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Contraceptive Drugs and Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Contraceptive Drugs and Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Contraceptive Drugs and Devices Sales Value Share by Application (2021-2032) Figure 28. Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Contraceptive Drugs and Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Contraceptive Drugs and Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Contraceptive Drugs and Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Contraceptive Drugs and Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Contraceptive Drugs and Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Contraceptive Drugs and Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Contraceptive Drugs and Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Contraceptive Drugs and Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Contraceptive Drugs and Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Contraceptive Drugs and Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Contraceptive Drugs and Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Contraceptive Drugs
  • Vaginal
  • Male/Female Contraceptive Devices
  • Oral
Applications
  • Hospitals
  • Pharmacies
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Merck
  • Pfizer
  • Bayer Healthcare
  • Warmer Chilcott
  • Pantarhei Bioscience
  • Mayer Laboratories
  • Church & Dwight
  • BioSante Pharmaceuticals
  • Agile Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptive Drugs and Devices Sales Value (2021-2032)
  4. 1.2.2 Global Contraceptive Drugs and Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Contraceptive Drugs and Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contraceptive Drugs and Devices Market Dynamics
  1. 2.1 Contraceptive Drugs and Devices Industry Trends
  2. 2.2 Contraceptive Drugs and Devices Industry Drivers
  3. 2.3 Contraceptive Drugs and Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drugs and Devices Industry Restraints
3 Contraceptive Drugs and Devices Market by Company
  1. 3.1 Global Contraceptive Drugs and Devices Company Revenue Ranking in 2025
  2. 3.2 Global Contraceptive Drugs and Devices Revenue by Company (2021-2026)
  3. 3.3 Global Contraceptive Drugs and Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Contraceptive Drugs and Devices Average Price by Company (2021-2026)
  5. 3.5 Global Contraceptive Drugs and Devices Company Ranking (2024-2026)
  6. 3.6 Global Contraceptive Drugs and Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Contraceptive Drugs and Devices Company Product Type and Application
  8. 3.8 Global Contraceptive Drugs and Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contraceptive Drugs and Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contraceptive Drugs and Devices Market by Type
  1. 4.1 Contraceptive Drugs and Devices Type Introduction
  2. 4.1.1 Injectable Contraceptive Drugs
  3. 4.1.2 Vaginal
  4. 4.1.3 Male/Female Contraceptive Devices
  5. 4.1.4 Oral
  6. 4.2 Global Contraceptive Drugs and Devices Sales Volume by Type
  7. 4.2.1 Global Contraceptive Drugs and Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Contraceptive Drugs and Devices Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Contraceptive Drugs and Devices Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Contraceptive Drugs and Devices Sales Value by Type
  11. 4.3.1 Global Contraceptive Drugs and Devices Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Contraceptive Drugs and Devices Sales Value by Type (2021-2032)
  13. 4.3.3 Global Contraceptive Drugs and Devices Sales Value Share by Type (2021-2032)
5 Contraceptive Drugs and Devices Market by Application
  1. 5.1 Contraceptive Drugs and Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Contraceptive Drugs and Devices Sales Volume by Application
  6. 5.2.1 Global Contraceptive Drugs and Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptive Drugs and Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Contraceptive Drugs and Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Contraceptive Drugs and Devices Sales Value by Application
  10. 5.3.1 Global Contraceptive Drugs and Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Contraceptive Drugs and Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Contraceptive Drugs and Devices Sales Value Share by Application (2021-2032)
6 Contraceptive Drugs and Devices Regional Sales and Value Analysis
  1. 6.1 Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Drugs and Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Drugs and Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Contraceptive Drugs and Devices Sales by Region (2027-2032)
  5. 6.3 Global Contraceptive Drugs and Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contraceptive Drugs and Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contraceptive Drugs and Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contraceptive Drugs and Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Contraceptive Drugs and Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contraceptive Drugs and Devices Sales Value (2021-2032)
  12. 6.6.2 North America Contraceptive Drugs and Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contraceptive Drugs and Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Contraceptive Drugs and Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contraceptive Drugs and Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contraceptive Drugs and Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contraceptive Drugs and Devices Sales Value (2021-2032)
  21. 6.9.2 South America Contraceptive Drugs and Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contraceptive Drugs and Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contraceptive Drugs and Devices Sales Value Share by Country, 2025 VS 2032
7 Contraceptive Drugs and Devices Country-level Sales and Value Analysis
  1. 7.1 Global Contraceptive Drugs and Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contraceptive Drugs and Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contraceptive Drugs and Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Contraceptive Drugs and Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Contraceptive Drugs and Devices Sales by Country (2027-2032)
  6. 7.4 Global Contraceptive Drugs and Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contraceptive Drugs and Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contraceptive Drugs and Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contraceptive Drugs and Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contraceptive Drugs and Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contraceptive Drugs and Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Bayer Healthcare
  20. 8.4.1 Bayer Healthcare Company Information
  21. 8.4.2 Bayer Healthcare Business Overview
  22. 8.4.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
  24. 8.4.5 Bayer Healthcare Recent Developments
  25. 8.5 Warmer Chilcott
  26. 8.5.1 Warmer Chilcott Company Information
  27. 8.5.2 Warmer Chilcott Business Overview
  28. 8.5.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
  30. 8.5.5 Warmer Chilcott Recent Developments
  31. 8.6 Pantarhei Bioscience
  32. 8.6.1 Pantarhei Bioscience Company Information
  33. 8.6.2 Pantarhei Bioscience Business Overview
  34. 8.6.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
  36. 8.6.5 Pantarhei Bioscience Recent Developments
  37. 8.7 Mayer Laboratories
  38. 8.7.1 Mayer Laboratories Company Information
  39. 8.7.2 Mayer Laboratories Business Overview
  40. 8.7.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
  42. 8.7.5 Mayer Laboratories Recent Developments
  43. 8.8 Church & Dwight
  44. 8.8.1 Church & Dwight Company Information
  45. 8.8.2 Church & Dwight Business Overview
  46. 8.8.3 Church & Dwight Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
  48. 8.8.5 Church & Dwight Recent Developments
  49. 8.9 BioSante Pharmaceuticals
  50. 8.9.1 BioSante Pharmaceuticals Company Information
  51. 8.9.2 BioSante Pharmaceuticals Business Overview
  52. 8.9.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
  54. 8.9.5 BioSante Pharmaceuticals Recent Developments
  55. 8.10 Agile Therapeutics
  56. 8.10.1 Agile Therapeutics Company Information
  57. 8.10.2 Agile Therapeutics Business Overview
  58. 8.10.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
  60. 8.10.5 Agile Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Drugs and Devices Value Chain Analysis
  2. 9.1.1 Contraceptive Drugs and Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Drugs and Devices Sales Mode & Process
  6. 9.2 Contraceptive Drugs and Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Drugs and Devices Distributors
  9. 9.2.3 Contraceptive Drugs and Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst